Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease

Heartburn affects 25% of the adult population on a monthly basis and represents the core symptom of gastro-oesophageal reflux disease (GORD). Treatment is readily available and puts a large demand on healthcare budgets. A majority of GORD patients show no endoscopic abnormalities and in daily practi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cochrane database of systematic reviews 2004-10 (4), p.CD002095-CD002095
Hauptverfasser:	van Pinxteren, B, Numans, M E, Bonis, P A, Lau, J
Format:	Artikel
Sprache:	eng
Schlagworte:	Endoscopy, Digestive System Enzyme Inhibitors - therapeutic use Gastroesophageal Reflux - drug therapy Gastrointestinal Agents - therapeutic use Heartburn - drug therapy Histamine H2 Antagonists - therapeutic use Humans Proton Pump Inhibitors Randomized Controlled Trials as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!